Table 2.
Study | Arrhythmia monitoring methodology | Protocol of AADs after ablation | Cryoablation protocol | Radiofrequency ablation protocol |
---|---|---|---|---|
Andrade | Implantable Loop Recorder | Discontinued after the blanking period | Cryoablation was performed with a lesion duration of 4 min or 2 min | The CF targeted prior to lesion delivery was 20 g (10–40 g), with a minimum individual FTI > 400 gs |
You | NR | NR | Cryoablation was performed up to 180 s and two times for each PV | Standardized RFCA procedure |
Giannopoulos | NR |
Discontinued after the blanking period |
Cryoablation energy was applied for 240 s; if no PV signals were recorded in a vein the time of energy delivery was reduced to 180 s | Standardized RFCA procedure |
Buist | ECG; 24–72 h Holter ECG | Discontinued after the blanking period | Cryo-energy applications were performed up to 240 s, with an additional number of cryo applications at the operator’s discretion | Power setting was adjusted between 30–40 w, RF application duration of 20 to 40 s, FTI > 400 gs |
Watanabe | ECG; Holter ECG | Discontinued after the blanking period | A 180 s-freeze was delivered to each PV | RF energy was delivered with a maximum power of 30 W, CF of 10–15 g |
Gunawardene | ECG ; 5-day Holter ECG | Discontinued after the ablation | Target application time was 240 s (332.0 + 159.3 s per PV and 1.54 + 0.76 cryo freezes per PV, as results) | RF energy was delivered with a maximum power of 30 W for 30–60 s, temperature limit of 45℃, minimal CF of 10 g |
AADs = antiarrhythmic drugs, ECG = electrocardiograph, PV = pulmonary vein, CF = contact force, FTI = force–time integral, RFCA = radiofrequency catheter ablation, NR = not reported.